TAR-200, A Bladder-Sparing Innovation for High-Risk NMIBC - Beyond the Abstract
Managing patients with high-risk non-muscle-invasive bladder cancer (HR-NMIBC) who are unresponsive to BCG remains a common and persistent challenge. Radical cystectomy, while effective, is a high-risk surgical intervention that many patients are either …